RNA Therapeutics and RNA Vaccines Market is anticipated to grow at a CAGR of over 68%, predicts Roots Analysis

Owing to their clinical potential to specifically target and treat various disease indications, the next generation RNA therapeutics and RNA vaccines have gained significant traction and are anticipated to revolutionize the healthcare and medical sector.

Roots Analysis is pleased to announce the publication of its recent study, titled, "RNA Therapeutics and RNA Vaccines Market, 2023-2035"

The report features an extensive study of the current market landscape, market size and future opportunities associated with the RNA vaccines and RNA therapeutics market, during the given forecast period.

To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/rna-therapeutics-market/request-quote.html

Further, the market report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Amongst other elements, the report includes:

1. A preface providing an introduction to the full report, RNA Therapeutics and RNA Vaccines Market, 2023-2035.
2. An outline of the systematic research methodology adopted to conduct the study on next generation RNA therapeutics and RNA vaccines market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of our findings.
3. An overview of economic factors that impact the overall next generation RNA therapeutics and RNA vaccines market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
4. An executive summary of the insights captured during our research, offering a high-level view of the current state of the next generation RNA therapeutics and RNA vaccines market and its likely evolution in the mid-to-long term.
5. A brief introduction to the next generation RNA therapeutics and RNA vaccines, highlighting their historical background, as well as information on their types, key aspects, key challenges and the advantages of using next generation RNA modalities.
6. A detailed assessment of the market landscape of more than 100 next generation RNA therapeutics and RNA vaccines that are either approved or being evaluated in different stages of development.
7. A detailed assessment of the market landscape of more than 35 technologies that are being developed / deployed to support the development of next generation RNA therapeutics and RNA vaccines.
8. Elaborate profiles of drug candidates that are in advanced stages of development (Phase II, III and above).
9. An in-depth analysis of completed and ongoing clinical trials of various next generation RNA therapeutics and RNA vaccines.
10. An in-depth analysis of patents related to next generation RNA therapeutics and RNA vaccines, filed / granted, since 2019.
11. An in-depth analysis of partnerships that have been inked between various stakeholders, since 2019.
12. A detailed analysis of various investments made by companies engaged in this industry since 2019.
13. An in-depth analysis of the various next generation RNA therapeutics and RNA vaccines focused initiatives undertaken by big pharma players.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/rna-therapeutics-market/request-sample.html

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

1. Type of Modality
Therapeutics
Vaccines

2. Type of Molecule
Replicating RNA (repRNA)
Self amplifying RNA (saRNA)
Self activating RNA (sacRNA)
Self activating mRNA (sa-mRNA)
Transfer RNA (tRNA)

3. Therapeutic Area
Infectious Diseases
Oncological Disorders
Pulmonary Disorders

4. Route of Administration
Intradermal
Intramuscular
Intravenous

5. Key Geographical Regions
North America
Europe
Asia-Pacific

Key companies / organizations covered in the report
1. Alphavax
2. Arcturus Therapeutics
3. Atyr Pharma
4. Gritstone Bio
5. HDT Bio
6. MiNA Therapeutics
7. VLP Therapeutics

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/rna-therapeutics-market.html

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Website: https://www.rootsanalysis.com

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.